SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-002037
Filing Date
2024-02-28
Accepted
2024-02-28 17:16:27
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A hrmy-20231231x10ka.htm   iXBRL 10-K/A 88707
2 EX-31.1 hrmy-20231231xex31d1.htm EX-31.1 8821
3 EX-31.2 hrmy-20231231xex31d2.htm EX-31.2 7934
  Complete submission text file 0001558370-24-002037.txt   491404

Data Files

Seq Description Document Type Size
4 EX-101.SCH hrmy-20231231.xsd EX-101.SCH 6698
5 EX-101.DEF hrmy-20231231_def.xml EX-101.DEF 39500
6 EX-101.LAB hrmy-20231231_lab.xml EX-101.LAB 40684
7 EX-101.PRE hrmy-20231231_pre.xml EX-101.PRE 23709
19 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20231231x10ka_htm.xml XML 21091
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39450 | Film No.: 24696901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)